CLINICAL_TRIALS
trial_result
· 2009-03-25
Clinical Trial Update: Long Term Safety and Tolerability of SR58611 in Patients With Major Depressive Disorder [Phase 3]
Summary
The document reports long-term safety and tolerability results from a Phase 3 trial of SR58611 in adults with major depressive disorder.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: Sanofi | Conditions: Major Depressive Disorders | Phase 3 | Status: COMPLETED